Global Free Fatty Acid Receptor 4 Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Advinus Therapeutics Ltd
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 AstraZeneca Plc
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 CymaBay Therapeutics Inc
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Dompe Farmaceutici SpA
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 GlaxoSmithKline Plc
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Merck & Co Inc
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Sancilio & Company Inc
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Non Alcoholic Fatty Liver Disease
  • 4.1.1 Overview
  • 4.1.2 Non Alcoholic Fatty Liver Disease Market Size and Forecast
• 4.2 Type 2 Diabets
  • 4.2.1 Overview
  • 4.2.2 Type 2 Diabets Market Size and Forecast
• 4.3 Metabolic Disorders
  • 4.3.1 Overview
  • 4.3.2 Metabolic Disorders Market Size and Forecast
• 4.4 Others
  • 4.4.1 Overview
  • 4.4.2 Others Market Size and Forecast

5 Market by Type

5.By CB-001

• 5.1 CB-001
  • 5.1.1 Overview
  • 5.1.2 CB-001 Market Size and Forecast
• 5.2 GSK-137647A
  • 5.2.1 Overview
  • 5.2.2 GSK-137647A Market Size and Forecast
• 5.3 SC-410
  • 5.3.1 Overview
  • 5.3.2 SC-410 Market Size and Forecast
• 5.4 Others
  • 5.4.1 Overview
  • 5.4.2 Others Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion